Showing 7201-7210 of 20895 results for "".
- Urolithiasis Directly Linked to Osteoporosis, Finds Studyhttps://reachmd.com/news/urolithiasis-directly-linked-to-osteoporosis-finds-study/2467597/Researchers have found that urolithiasis, commonly known as kidney stones, has a direct causal relationship with osteoporosis (OP), independent of environmental factors. A recent study was published in The Journal of Clinical Endocrinology and Metabolism by Zijie Z. and colleague
- American Football Participation Linked to Parkinsonism Risk in People with CTEhttps://reachmd.com/news/american-football-participation-linked-to-parkinsonism-risk-in-people-with-cte/2467569/Parkinsonism was prevalent among deceased contact sports participants with chronic traumatic encephalopathy (CTE) and was associated with repetitive head impacts (RHIs), substantia nigra (SN) Lewy bodies (LBs), neurofibrillary tangles (NFTs), dopaminergic neuronal loss,
- Selpercatinib Approved to Treat Some Adult and Pediatric Thyroid Cancershttps://reachmd.com/news/selpercatinib-approved-to-treat-some-adult-and-pediatric-thyroid-cancers/2467606/The RET inhibitor is now fully approved to treat certain patients with RET fusion-positive thyroid cancers. The U.S. Food and Drug Administration (FDA) has
- Could Taking Vinegar Every Day Help Reduce Depression?https://reachmd.com/news/could-taking-vinegar-every-day-help-reduce-depression/2467578/In a recent study published in the journal Nutrients, researchers in the United States investigated the effects of daily vinegar ingestion on depression symptoms in overwe
- Mutations in DNA Damage Repair Genes Associated with Response to Cisplatin Bladder Cancer: Prospective Validation from SWOG S1314 trialhttps://reachmd.com/news/mutations-in-dna-damage-repair-genes-associated-with-response-to-cisplatin-bladder-cancer-prospective-validation-from-swog-s1314-trial/2467608/An analysis of pre-treatment tumor specimens from 105 patients with localized muscle-invasive bladder cancer found that the presence of a mutation in any one of three genes, all known to be involved in DNA damage repair, was associated with complete pathologic response to cisplatin-based neo
- Nemolizumab Meets Key Endpoints in ARCADIA Studieshttps://reachmd.com/news/nemolizumab-meets-key-endpoints-arcadia-studies/2467533/Nemolizumab, a monoclonal antibody targeting the IL-31 receptor, showed efficacy for the treatment of atopic dermatitis, particularly pruritus and sleep disturbance, according to an announcement from Galderma. The full results of the phase III ARCADIA 1 and 2 trials for nemolizumab were pu
- Association Between Telomere Length and Erectile Dysfunction: A Cross-Sectional Studyhttps://reachmd.com/news/association-between-telomere-length-and-erectile-dysfunction-a-cross-sectional-study/2467595/IntroductionErectile dysfunction is a frequently observed disorder characterized by the persistent inability to achieve or maintain a satisfactory penile erection necessary for a fulfilling sexual experience (
- ZORYVE Cream 0.15% for AD Commercially Available This Weekhttps://reachmd.com/news/zoryve-cream-015-ad-commercially-available-week/2467570/Arcutis Biotherapeutics announced the commercial launch of ZORYVE® (roflumilast) cream 0.15% for the treatment of mild-to-moderate atopic dermatitis in adults and children down to age 6 in the United States, along with a co-promotion agreement with Kowa Pharmaceuticals America, Inc. ZORYVE is a o
- Machine Learning Shows Potential for Predicting Multiple Sclerosis Progressionhttps://reachmd.com/news/machine-learning-shows-potential-for-predicting-multiple-sclerosis-progression/2467547/Credit: De Brouwer et al., 2024, PLOS Digital Health, CC-BY 4.0 (creativecommons.org/licenses/by/4.0/) Machine learning models can reliably inform clinicians about the disability progression of mul
- Cellular Therapy Receives FDA Fast Track Designation for Potential Treatment of Alzheimer Diseasehttps://reachmd.com/news/cellular-therapy-receives-fda-fast-track-designation-for-potential-treatment-of-alzheimer-disease/2467567/Lomecel-B (Longeveron, Miami, Fl), an allogenic cellular therapy, has been granted Fast Track Designation by the Food and Drug Administration (FDA) for investigation for potential applications in Alzheimer disease (AD), aging-related frailty, and hypoplastic left heart syndrome. The